Literature DB >> 28161714

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.

Simon L Currie1,2, Desmond K W Lau3, Jedediah J Doane1,2, Frank G Whitby4, Mark Okon3, Lawrence P McIntosh3, Barbara J Graves1,2,5.   

Abstract

Autoinhibition enables spatial and temporal regulation of cellular processes by coupling protein activity to surrounding conditions, often via protein partnerships or signaling pathways. We report the molecular basis of DNA-binding autoinhibition of ETS transcription factors ETV1, ETV4 and ETV5, which are often overexpressed in prostate cancer. Inhibitory elements that cooperate to repress DNA binding were identified in regions N- and C-terminal of the ETS domain. Crystal structures of these three factors revealed an α-helix in the C-terminal inhibitory domain that packs against the ETS domain and perturbs the conformation of its DNA-recognition helix. Nuclear magnetic resonance spectroscopy demonstrated that the N-terminal inhibitory domain (NID) is intrinsically disordered, yet utilizes transient intramolecular interactions with the DNA-recognition helix of the ETS domain to mediate autoinhibition. Acetylation of selected lysines within the NID activates DNA binding. This investigation revealed a distinctive mechanism for DNA-binding autoinhibition in the ETV1/4/5 subfamily involving a network of intramolecular interactions not present in other ETS factors. These distinguishing inhibitory elements provide a platform through which cellular triggers, such as protein-protein interactions or post-translational modifications, may specifically regulate the function of these oncogenic proteins.
© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28161714      PMCID: PMC5389675          DOI: 10.1093/nar/gkx068

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  68 in total

1.  Structure of Cdc42 bound to the GTPase binding domain of PAK.

Authors:  A Morreale; M Venkatesan; H R Mott; D Owen; D Nietlispach; P N Lowe; E D Laue
Journal:  Nat Struct Biol       Date:  2000-05

2.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

3.  Two functionally distinct domains responsible for transactivation by the Ets family member ERM.

Authors:  M P Laget; P A Defossez; O Albagli; J L Baert; F Dewitte; D Stehelin; Y de Launoit
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

4.  Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix.

Authors:  J M Petersen; J J Skalicky; L W Donaldson; L P McIntosh; T Alber; B J Graves
Journal:  Science       Date:  1995-09-29       Impact factor: 47.728

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association.

Authors:  Sean M Green; H Jerome Coyne; Lawrence P McIntosh; Barbara J Graves
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc.

Authors:  Dalia I Hammoudeh; Ariele Viacava Follis; Edward V Prochownik; Steven J Metallo
Journal:  J Am Chem Soc       Date:  2009-06-03       Impact factor: 15.419

9.  A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.

Authors:  Marius S Pop; Nicolas Stransky; Colin W Garvie; Jean-Philippe Theurillat; Emily C Hartman; Timothy A Lewis; Cheng Zhong; Elizabeth K Culyba; Fallon Lin; Douglas S Daniels; Raymond Pagliarini; Lucienne Ronco; Angela N Koehler; Levi A Garraway
Journal:  Mol Cancer Ther       Date:  2014-04-15       Impact factor: 6.261

10.  New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

Authors:  Charles E Massie; Boris Adryan; Nuno L Barbosa-Morais; Andy G Lynch; Maxine G Tran; David E Neal; Ian G Mills
Journal:  EMBO Rep       Date:  2007-08-17       Impact factor: 8.807

View more
  12 in total

1.  Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.

Authors:  Bethany J Madison; Kathleen A Clark; Niraja Bhachech; Peter C Hollenhorst; Barbara J Graves; Simon L Currie
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

2.  Intrinsically disordered regions regulate both catalytic and non-catalytic activities of the MutLα mismatch repair complex.

Authors:  Yoori Kim; Christopher M Furman; Carol M Manhart; Eric Alani; Ilya J Finkelstein
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

3.  Flipping states: a few key residues decide the winning conformation of the only universally conserved transcription factor.

Authors:  Da Shi; Dmitri Svetlov; Ruben Abagyan; Irina Artsimovitch
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

4.  Connecting sequence features within the disordered C-terminal linker of Bacillus subtilis FtsZ to functions and bacterial cell division.

Authors:  Min Kyung Shinn; Megan C Cohan; Jessie L Bullock; Kiersten M Ruff; Petra A Levin; Rohit V Pappu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

5.  ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.

Authors:  Simon L Currie; Jedediah J Doane; Kathryn S Evans; Niraja Bhachech; Bethany J Madison; Desmond K W Lau; Lawrence P McIntosh; Jack J Skalicky; Kathleen A Clark; Barbara J Graves
Journal:  J Mol Biol       Date:  2017-07-17       Impact factor: 5.469

6.  The human CRY1 tail controls circadian timing by regulating its association with CLOCK:BMAL1.

Authors:  Gian Carlo G Parico; Ivette Perez; Jennifer L Fribourgh; Britney N Hernandez; Hsiau-Wei Lee; Carrie L Partch
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

7.  Modulation of the HIV nucleocapsid dynamics finely tunes its RNA-binding properties during virion genesis.

Authors:  Assia Mouhand; Anissa Belfetmi; Marjorie Catala; Valéry Larue; Loussiné Zargarian; Franck Brachet; Robert J Gorelick; Carine Van Heijenoort; Gilles Mirambeau; Pierre Barraud; Olivier Mauffret; Carine Tisné
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

8.  miR-129-5p inhibits prostate cancer proliferation via targeting ETV1.

Authors:  Ge Gao; Dianhui Xiu; Bin Yang; Daju Sun; Xin Wei; Youpeng Ding; Yanan Ma; Zhixin Wang
Journal:  Onco Targets Ther       Date:  2019-05-09       Impact factor: 4.147

9.  Reversible fold-switching controls the functional cycle of the antitermination factor RfaH.

Authors:  Philipp Konrad Zuber; Kristian Schweimer; Paul Rösch; Irina Artsimovitch; Stefan H Knauer
Journal:  Nat Commun       Date:  2019-02-11       Impact factor: 14.919

10.  Development of High-Throughput Screening Assays for Inhibitors of ETS Transcription Factors.

Authors:  Simon L Currie; Steven L Warner; Hariprasad Vankayalapati; Xiaohui Liu; Sunil Sharma; David J Bearss; Barbara J Graves
Journal:  SLAS Discov       Date:  2018-09-11       Impact factor: 3.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.